RIGEL PHARMACEUTICALS INC Annual Operating Margin in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Operating Margin history and growth rate from 2016 to 2023.
  • Rigel Pharmaceuticals Inc Operating Margin for the quarter ending September 30, 2024 was 6.03 %.
  • Rigel Pharmaceuticals Inc annual Operating Margin for 2023 was -17.5 %, a 62.1% increase from 2022.
  • Rigel Pharmaceuticals Inc annual Operating Margin for 2022 was -46.2 %, a 452% decline from 2021.
  • Rigel Pharmaceuticals Inc annual Operating Margin for 2021 was -8.37 %, a 68.6% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -17.5 +28.7 +62.1% Jan 1, 2023 Dec 31, 2023
2022 -46.2 -37.8 -452% Jan 1, 2022 Dec 31, 2022
2021 -8.37 +18.3 +68.6% Jan 1, 2021 Dec 31, 2021
2020 -26.7 +89.9 +77.1% Jan 1, 2020 Dec 31, 2020
2019 -117 +46.8 +28.6% Jan 1, 2019 Dec 31, 2019
2018 -163 +1.61K +90.8% Jan 1, 2018 Dec 31, 2018
2017 -1.78K -1.43K -419% Jan 1, 2017 Dec 31, 2017
2016 -342 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.